A fundamental analysis of Akzo Nobel India Ltd. (AKZOINDIA) covering revenue trends, profitability, valuation, and shareholding patterns.
Akzo Nobel India Revenue Trend
Revenue for Akzo Nobel India Ltd. came in at ₹4,119 Cr in FY2025, growing 3.0% year-over-year.
Stepping back, the 10-year revenue CAGR of 5.0% shows Akzo Nobel India Ltd. has been growing at a moderate, sustainable pace.
Akzo Nobel India Ltd.'s ₹4,119 Cr revenue base puts it in the mid-sized bracket among paints companies in India.
Revenue has moved in the same direction for 4 years running, suggesting the growth trend has structural legs.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹4,119 Cr | +3.0% |
| FY2024 | ₹3,997 Cr | +4.4% |
| FY2023 | ₹3,830 Cr | +20.8% |
| FY2022 | ₹3,171 Cr | +29.7% |
| FY2021 | ₹2,445 Cr | — |
View Akzo Nobel India Ltd.'s full 10-year revenue trend with CAGR analysis →
Akzo Nobel India Profitability
Bottom-line growth was muted: Akzo Nobel India Ltd. earned ₹429 Cr in FY2025, similar to FY2024.
Not much change on the margin front — net profit margin held at roughly 10.4% in FY2025.
Looking at per-share numbers, diluted EPS was ₹94.31 in FY2025 — up from ₹93.68.
Is Akzo Nobel India Undervalued
Using the P/E Ratio methodology, the calculated intrinsic value comes to ₹3,348.
Akzo Nobel India Ltd. shares are currently trading at ₹2,986.80.
Craytheon also calculates intrinsic value using the EPS Growth and DCF models. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹3,348 | 12.1% upside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Akzo Nobel India Ltd. with detailed assumptions →
Akzo Nobel India Shareholding Pattern
At 61.2%, the promoter holding is lower than the 74.8% seen 4 quarters ago.
The FII stake is at 8.7% as of December 2025, compared to 3.7% in the year-ago period.
Domestic investors held 20.6% of the company as of December 2025, up year-over-year from 8.5%.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Dec 2025 | 61.2% | 8.7% | 20.6% | 9.6% |
| Sep 2025 | 69.8% | 8.0% | 13.8% | 8.5% |
| Jun 2025 | 74.8% | 3.7% | 8.6% | 13.0% |
| Mar 2025 | 74.8% | 3.7% | 8.5% | 13.1% |
Track quarterly shareholding changes for Akzo Nobel India Ltd. →
Akzo Nobel India Balance Sheet
Proportional view as of 13 Apr 2026. Hover blocks for details.
Assets
Liabilities & Equity
Total assets stood at ₹29.03B at the end of FY2025, down 0.0% from ₹29.04B a year earlier.
Other Assets is the largest block at 32.7%, followed by Inventories at 20.8% and Receivables at 20.1%.
Equity makes up 45.8% of liabilities and equity, with debt at 2.1% and operating liabilities at 52.0%. Over the year, debt is up 2.8% and equity is up 0.0%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 3.01B |
| Receivables | 5.85B |
| Inventories | 6.05B |
| Property, Plant & Equipment | 4.62B |
| Intangibles & Goodwill | 19.00M |
| Other Assets | 9.49B |
| Category | Value |
|---|---|
| Equity | 13.30B |
| Short-term Debt | 173.00M |
| Long-term Debt | 448.00M |
| Trade Payables | 9.56B |
| Other Liabilities | 5.55B |
What Stands Out About Akzo Nobel India
To sum up Akzo Nobel India Ltd.'s financial position: the data paints a clear picture for investors evaluating this paints stock.
Revenue of ₹4,119 Cr in FY2025, up 3.0% year-over-year.
Long-term revenue has been compounding at 5.0% annually over 10 years.
The company is profitable, with a net margin of 10.4% and net income of ₹429 Cr.
The P/E Ratio model implies 12.1% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
See the full picture — Craytheon tracks 10 years of financial data with interactive charts, growth trends, and three valuation models for Akzo Nobel India Ltd..